TRAUMA
No significant effect of topical FS or TXA on blood loss in cases of sub-capital femoral fracture
Arch Orthop Trauma Surg. 2019 May;139(5):597-604. doi: 10.1007/s00402-018-3089-4161 patients with a sub-capital femoral fracture and undergoing arthroplasty were randomized to one of three groups: topical fibrin sealant application, topical tranexamic acid applications, or standard haemostasis through electrocoagulation alone. The primary outcome of this study was volume of blood loss to postoperative drainage. Results demonstrated no significant differences between the three groups in the primary outcome, or in secondary outcomes of total blood loss, hidden blood loss, haemoglobin level, and rate of patients who required transfusion.
Unlock the full ACE Report
You have access to {0} free articles per month.Click below to unlock and view this {1}
Unlock NowCritical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or upgrade today and gain access to all OrthoEvidence content for just $1.99 per week.
Already have an account? Log in
Subscribe to "The Pulse"
Evidence-Based Orthopaedics direct to your inbox.
{0} of {1} free articles
Become an OrthoEvidence Premium Member. Expand your perspective with high-quality evidence.
Upgrade Now
